Author: Beata Staszkow

Orthostatic Hypotension from Medications: Why You Feel Dizzy When You Stand Up

Beata Staszkow
|
February 27
|
2

Dizziness when standing up? It might be your medication. Orthostatic hypotension from drugs is common, dangerous, and often preventable. Learn which meds cause it, how to spot it, and how to fix it.

Alcohol and Sleep Medications: Why Even One Drink Can Be Deadly

Beata Staszkow
|
February 21
|
9

Mixing alcohol with sleep medications like Ambien or Unisom can cause fatal respiratory depression, memory loss, and dangerous sleep behaviors. Even one drink can be deadly. Here’s what you need to know.

Cholinergic Urticaria: Heat-Induced Hives and How to Prevent Them

Beata Staszkow
|
February 14
|
11

Cholinergic urticaria, or heat hives, is a skin condition triggered by rising body temperature. Learn how it works, what triggers it, and how to prevent and manage outbreaks with antihistamines, lifestyle changes, and new treatments.

Opioids with MAOIs: Dangerous Interactions and How to Avoid Them

Beata Staszkow
|
February 13
|
15

Combining opioids with MAOIs can trigger life-threatening serotonin syndrome. Learn which opioids are dangerous, why the interaction happens, and how to avoid fatal mistakes with safe alternatives and strict washout periods.

VA Generic Coverage: How Veterans Affairs Formularies Control Prescription Costs and Access

Beata Staszkow
|
February 7
|
11

The VA formulary ensures veterans get affordable, effective generic medications with low copays. Learn how the three-tier system works, what drugs are covered in 2025, and how to navigate prescriptions through VA pharmacies.

China vs India Pharmaceutical Manufacturing: FDA Risks and Monitoring Explained

Beata Staszkow
|
February 5
|
13

China and India dominate global pharmaceutical manufacturing but face different regulatory risks. The FDA's monitoring shows India has better compliance with 100 approved plants versus China's 28. Learn why companies are shifting supply chains and how API dependency affects drug safety.

COPD Triple Inhaler Therapy: Reducing Exacerbations and Improving Management

Beata Staszkow
|
February 4
|
13

Triple inhaler therapy combines three medications for COPD management. Learn how it reduces exacerbations, who qualifies, and real-world pros and cons. Based on 2024 GOLD guidelines, this treatment is targeted for specific patients with frequent flare-ups and elevated eosinophil levels.

Progressive Multifocal Leukoencephalopathy Risk from Immunosuppressants: What You Need to Know

Beata Staszkow
|
February 3
|
12

PML is a rare but deadly brain infection triggered by the JC virus in people taking immunosuppressants. Learn which drugs carry the highest risk, how to detect PML early, and what steps can save your life.

ANDA Process: Legal Requirements for Generic Drug Approval in the U.S.

Beata Staszkow
|
January 30
|
11

The ANDA process lets generic drug makers get FDA approval by proving bioequivalence to brand-name drugs, cutting costs and speeding access. Legal requirements include identical active ingredients, strict CMC standards, patent certifications, and GDUFA fees.

Mental Illness and Medication Interactions: Navigating Complex Polypharmacy

Beata Staszkow
|
January 28
|
10

Psychiatric polypharmacy-taking multiple mental health meds at once-is common but often risky. Learn why it happens, who’s most at risk, and how to safely reduce unnecessary drugs to improve health and quality of life.